Curium Announces the Submission of its Marketing

Curium Announces the Submission of its Marketing

Submission follows the completion of Phase III PYTHON clinical trial of [18F]-DCFPyL for recurrent prostate cancer in Europe in May 2022 Phase III PYTHON clinical trial results to be presented at the 35th Annual Congress of the European Association of Nuclear Medicine, October 15-19, 2022 in Barcelona, ​​Spain PARIS, June 27, 2022 (GLOBE NEWSWIRE) — … Read more

South Carolina researchers tackle health disparities using genetics

South Carolina researchers tackle health disparities using genetics

Quenton Tompkins’ family tree is deeply rooted in rural McCormick County, South Carolina. His grandfather was a sharecropper in McCormick. His mother, who turns 88 this month, grew up as the youngest of 24 children. Branches of aunts, uncles, and cousins ​​now stretch from Florida to Chicago. And although 48-year-old Tompkins has heard plenty of … Read more

Genetic Risk Score Identifies Lifetime Prostate Cancer Risk

Genetic Risk Score Identifies Lifetime Prostate Cancer Risk

According to data presented at the 2021 American Society of Hematology Annual Meeting, an updated International Prognosis Scoring System (IPSS) for myelodysplastic syndromes (MDS) that incorporates gene mutations (IPSS-M) led to improved discrimination compared with the revised IPSS (IPSS-M) R). The IPSS-M, which considers clinical, cytogenetic, and genetic parameters, reclassified nearly half of patients studied. … Read more